IRS: Treatment of over-the-counter drugs under health flexible spending accounts (FSAs) and health reimbursement arrangements (HRAs) - Notice 2010-59

The Food Marketing Institute (FMI) appreciates the opportunity to respond to the Internal Revenue Service’s (IRS) request for comment on revisions to the treatment of over-the-counter (OTC) drugs under FSAs as required in Section 9003 of the Patient Protection and Affordable Care Act (PPACA)

Full Comments